Early Experience with Ahmed Clear Path Glaucoma Drainage Device in Childhood Glaucoma

Date Published:

2021 Apr 23

Abstract:

PURPOSE: To evaluate the short-term outcomes of Ahmed Clear Path (ACP) valveless glaucoma drainage device in childhood glaucoma. METHODS: Retrospective chart review of all patients ≤16 years with childhood glaucoma who had ACP implantation at Boston Children's Hospital from December 2019 to June 2020 with at least 6 months follow-up period. RESULTS: The study included 7 eyes of 5 patients implanted by a single surgeon. The median follow-up was 12 months. The mean IOP was reduced from 36±3.5▒mmHg on a mean of 2.7±0.6 glaucoma medications preoperatively to a mean IOP of 12.4±2.8▒mmHg (P<0.001) on a mean of 0.7±0.8 medications postoperatively at final follow-up (P=0.0009). Complete success was achieved in 4 eyes while qualified success was achieved in 3 eyes. CONCLUSION: The ACP GDD provided good short term IOP control and technical advantages for implantation for pediatric eyes were observed.

Last updated on 05/01/2021